Animal model for the study of the relationship between lower urinary tract symptoms/bladder outlet obstruction and erectile dysfunction

International Journal of Urology

Volumn 18, Issue 10, 2011, Pages 710-715

  Kobayashi, Ko ^a   Kato, Ryuichi ^a   Hisasue, Shin ichi ^a   Yamashita, Shinichi ^a   Tanaka, Toshiaki ^a   Masumori, Naoya ^a   Tsukamoto, Taiji ^a  

^a SAPPORO MEDICAL UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Bladder outlet obstruction; Endothelial nitric oxide synthase; Erectile dysfunction; Lower urinary tract symptoms

Indexed keywords

ENDOTHELIAL NITRIC OXIDE SYNTHASE; MESSENGER RNA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLADDER FUNCTION; BLADDER NECK STENOSIS; CONTROLLED STUDY; DISEASE SEVERITY; ERECTILE DYSFUNCTION; GENE; LOWER URINARY TRACT SYMPTOM; MALE; MICTURITION; NONHUMAN; PENIS; PENIS ERECTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SHAM PROCEDURE; SMOOTH MUSCLE RELAXATION; SPRAGUE DAWLEY RAT;

ANIMALS; DISEASE MODELS, ANIMAL; ERECTILE DYSFUNCTION; LOWER URINARY TRACT SYMPTOMS; MALE; RATS; RATS, SPRAGUE-DAWLEY; URINARY BLADDER NECK OBSTRUCTION;

EID: 80053091817     PISSN: 09198172     EISSN: 14422042     Source Type: Journal    
DOI: 10.1111/j.1442-2042.2011.02823.x     Document Type: Article

References (22)

1. Rosen RC, Giuliano F, Carson CC. Sexual dysfunction and lower urinary tract symptoms (LUTS) associated with benign prostatic hyperplasia (BPH). Eur. Urol. 2005; 47: 824-37.
2. McVary KT. Erectile dysfunction and lower urinary tract symptoms secondary to BPH. Eur. Urol. 2005; 47: 838-45.
3. McVary KT. Lower urinary tract symptoms and sexual dysfunction: epidemiology and pathophysiology. BJU Int. 2006; 97 (Suppl. 2): 23-8.
4. Macfarlane GJ, Botto H, Sagnier PP, Teillac P, Richard F, Boyle P. The relationship between sexual life and urinary condition in French community. J. Clin. Epidemiol. 1996; 49: 1171-6.
5. Frankel SJ, Donovan JL, Peters TI etal. Sexual function in men with lower urinary tract symptoms. J. Clin. Epidemiol. 1998; 51: 677-85.
6. Martin-Morales A, Sanchez-Cruz JJ, Saenz de Tejada I, Rodriguez-Vela L, Jimenez-Cruz JF, Burgos-Rodriguez R. Prevalence and independent risk factors for erectile dysfunction in Spain: results of the Epidemiologia de la Disfuncion Erectil Masculina Study. J. Urol. 2001; 166: 569-75.
7. Braun MH, Sommer F, Haupt G, Mathers MJ, Reifenrath B, Engelmann UH. Lower urinary tract symptoms and erectile dysfunction: co-morbidity or typical "aging male" symptoms? Results of the "Cologne Male Survey". Eur. Urol. 2003; 44: 588-94.
8. Boyle P, Robertson C, Mazzetta C etal. The association between lower urinary tract symptoms and erectile dysfunction in four centres: the UrEpik study. BJU Int. 2003; 92: 719-25.
9. Rosen R, Altwein J, Boyle P etal. Lower urinary tract symptoms and male sexual dysfunction: the multinational survey of the aging male (MSAM-7). Eur. Urol. 2003; 44: 637-49.
10. Vallancien G, Emberton M, Harving N, van Moorselaar RJ; Alf-One Study Group. Sexual dysfunction in 1274 European men suffering from lower urinary tract symptoms. J. Urol. 2003; 169: 2257-61.
11. Li MK, Garcia KA, Rosen R. Lower urinary tract symptoms and male sexual dysfunction in Asia: a survey of aging men from five Asian countries. BJU Int. 2005; 96: 1339-54.
12. Chang S, Hypolite JA, Zderic SA, Wein AJ, Chacko S, Disanto ME. Increased corpus cavernosum smooth muscle tone associated with partial bladder outlet obstruction is mediated via Rho-kinase. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2005; 289: R1124-30.
13. Khan MA, Dashwood MR, Thompson CS, Auld J, Morgan RJ, Mikhailidis DP. Down-regulation of endothelin-B receptor sites in cavernosal tissue of a rabbit model of partial bladder outlet obstruction: potential clinical relevance. World J. Urol. 1999; 17: 290-5.
14. Gur S, Sikka SC, Chandra S etal. Alfuzosin attenuates erectile dysfunction in rats with partial bladder outlet obstruction. BJU Int. 2008; 102: 1651-7.
15. Aldridge N, Kim HW, Motamedi A, Rajasekaran M. Chronic partial bladder outlet obstruction does not impair erectile function in male rats. BJU Int. 2010; 106: 572-7.
16. Kitta T, Kakizaki H, Tanaka H etal. An alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionate glutamate-receptor antagonist can inhibit premicturition contractions in rats with bladder outlet obstruction. BJU Int. 2007; 100: 181-6.
17. Zvara P, Kliment J Jr, DeRoss AL etal. Differential expression of bladder neurotrophic factor mRNA in male and female rats after bladder outflow obstruction. J. Urol. 2002; 168: 2682-8.
18. Hashimoto T, Nagabukuro H, Doi T. Effects of the selective acetylcholinesterase inhibitor TAK-802 on the voiding behavior and bladder mass increase in rats with partial bladder outlet obstruction. J. Urol. 2005; 174: 1137-41.
19. Kaiho Y, Nishiguchi J, Kwon DD etal. The effects of a type 4 phosphodiesterase inhibitor and the muscarinic cholinergic antagonist tolterodine tartrate on detrusor overactivity in female rats with bladder outlet obstruction. BJU Int. 2008; 101: 615-20.
20. Kato R, Wolfe D, Coyle CH etal. Herpes simplex virus vector-mediated delivery of neurturin rescues erectile dysfunction of cavernous nerve injury. Gene Ther. 2009; 16: 26-33.
21. Hisasue S, Kato R, Sato Y, Suetomi T, Tabata Y, Tsukamoto T. Cavernous nerve reconstruction with a biodegradable conduit graft and collagen sponge in the rat. J. Urol. 2005; 173: 286-91.
22. Suetomi T, Hisasue S, Sato Y, Tabata Y, Akaza H, Tsukamoto T. Effect of basic fibroblast growth factor incorporatig gelatin microsphires on erectile function in the diabetic rat. J. Urol. 2005; 173: 1423-8.